No Data
No Data
Boji Medical TechnologyLtd's (SZSE:300404) Earnings Might Be Weaker Than You Think
Broge Pharmaceuticals: 2024 Semi-Annual Report Summary
Broge Pharmaceuticals: Semi-Annual Report 2024
Boji Medical Technology (300404.SZ) has reached a strategic cooperation with Boao Jingfang in the field of innovative drugs for traditional Chinese medicine.
Boji Medical Technology (300404.SZ) announced that the company and its wholly-owned subsidiary Xinglin Traditional Chinese Medicine Technology (Guangzhou) Limited...
Boji Medical Technology (300404.SZ) released its performance for the first half of the year, with a net income of 30.1351 million yuan, an increase of 71.04%.
Boji Medical Technology (300404.SZ) released its 2024 interim report, with a revenue of 0.341 billion...
boji medical technology (300404.SZ): net income in the first half of the year was 30.1351 million yuan, a year-on-year increase of 71.04%.
On August 26, Boji Medical Technology (300404.SZ) announced its semi-annual report for 2024, with revenue of 0.341 billion yuan, a year-on-year increase of 46.92%; net income attributable to shareholders of the listed company was 30.1351 million yuan, a year-on-year increase of 71.04%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.6604 million yuan, a year-on-year increase of 164.08%; basic earnings per share was 0.0789 yuan.
No Data
No Data